Enhanced levels of a protein that induces the creation of fatty acid can lead to sepsis, a leading cause of death for patients in intensive care units, new research has found.
The UCP2 protein is enhanced in patients with sepsis, the findings showed.
"These results identify UCP2 as a potential therapeutic target in inflammatory diseases such as sepsis," said Augustine Choi from Weill Cornell Medical College, New York.
The excessive systemic inflammation in individuals with sepsis damages organs and can lead to death.
Therapeutic options for sepsis are limited and the factors that promote this excessive response to infection are poorly understood.
In mouse model of sepsis, lack of this protein ( UCP2) improved survival.
The authors determined that expression of UCP2 induces fatty acid synthesis, which in turn activates inflammatory pathways.
Given the roles of UCP2 in metabolic changes triggered by the immune response, further investigation of UCP2 in the context of cellular metabolism may be useful for elucidating mechanisms of human diseases, the researchers noted.
The study appeared in the Journal of Clinical Investigation.
--Indo-Asian news Service
gb/pku/vm
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
